Illumina, Inc. - Common Stock (NQ:ILMN)

278.20 +7.16 (+2.64%)

Delayed Quote Updated: 10:56 AM EDT, Oct 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

40 41 Next >

Illumina Inc (NASDAQ:ILMN) Q2 2025 Earnings: Mixed Results with Revenue Miss and EPS Beat ↗

July 31, 2025

Illumina's Q2 2025 earnings show mixed results: revenue missed estimates at $1.059B (-3% YoY), but EPS beat at $1.19. Shares dipped 1.18% post-report.

Via Chartmill

Illumina (NASDAQ:ILMN) Surprises With Q2 Sales

July 31, 2025

Genomics company Illumina (NASDAQ:ILMN) beat Wall Street’s revenue expectations in Q2 CY2025, but sales fell by 3% year on year to $1.06 billion. Its non-GAAP profit of $0.36 per share was 64.4% below...

Via StockStory

Earnings Scheduled For July 31, 2025 ↗

July 31, 2025

Via Benzinga

Illumina (ILMN) To Report Earnings Tomorrow: Here Is What To Expect

July 29, 2025

Genomics company Illumina (NASDAQ:ILMN) will be reporting earnings this Thursday afternoon. Here’s what to expect.

Via StockStory

Topics Artificial Intelligence

Illumina (ILMN) Stock Is Up, What You Need To Know

July 28, 2025

Shares of genomics company Illumina (NASDAQ:ILMN) jumped 3.7% in the pre-market session after analysts at Robert W. Baird increased their price target on the life sciences company's stock to $105.00....

Via StockStory

Topics Artificial Intelligence

12 Analysts Assess Illumina: What You Need To Know ↗

July 28, 2025

Via Benzinga

1 Profitable Stock with Exciting Potential and 2 We Question

July 21, 2025

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

Via StockStory

Illumina Stock: What Went Wrong And Why It's Best To Stay Away ↗

July 17, 2025

According to the Adhishthana Principles, Illumina stock may remain under pressure for over 18 years — here's why.

Via Benzinga

Why Illumina (ILMN) Shares Are Falling Today

July 09, 2025

Shares of genomics company Illumina (NASDAQ:ILMN) fell 4.2% in the morning session after a Citi analyst downgraded the stock to 'Sell' from 'Neutral' and lowered the price target.

Via StockStory

Topics Government World Trade

Where Illumina Stands With Analysts ↗

July 08, 2025

Via Benzinga

Illumina (ILMN) Stock Trades Down, Here Is Why

July 07, 2025

Shares of genomics company Illumina (NASDAQ:ILMN) fell 3.6% in the afternoon session after the major indices pulled back (Nasdaq -0.8%, S&P 500 -0.77%), largely due to escalating concerns surrounding...

Via StockStory

Topics Artificial Intelligence Government Stocks

iRhythm Technologies Announces Board Member Retirements and New Director Appointments

July 07, 2025

From iRhythm

Via GlobeNewswire

5 Must-Read Analyst Questions From Illumina’s Q1 Earnings Call

July 03, 2025

Illumina’s first quarter results reflected ongoing challenges in the global genomics market, as the company’s performance fell short of market expectations, prompting a negative reaction from...

Via StockStory

Topics Earnings World Trade

“Mag 7 Undercard Movers: IBO, SNYR, CTOR, PNPN.V, LAB – Breakthroughs in Military Defense, Tech, Medical & Healthcare Fuel Market Buzz”

June 23, 2025

Via AB Newswire

Topics Artificial Intelligence

SomaLogic Acquisition Marks Next Step In Illumina's Advanced Biomarker Push ↗

June 23, 2025

Illumina will acquire SomaLogic to expand in proteomics, adding new revenue streams and accelerating tech development in multiomics.

Via Benzinga

1 of Wall Street’s Favorite Stock to Target This Week and 2 to Brush Off

June 20, 2025

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,...

Via StockStory

Topics Energy

3 Reasons ILMN is Risky and 1 Stock to Buy Instead

June 18, 2025

What a brutal six months it’s been for Illumina. The stock has dropped 33.6% and now trades at $89.03, rattling many shareholders. This may have investors wondering how to approach the situation.

Via StockStory

Retail Investors Flock To Incyte As Drug Data, Qiagen Deal Fuel Optimism ↗

June 16, 2025

Stifel also upgraded the stock to ‘Buy’ with a $107 price target.

Via Stocktwits

Datadog To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Wednesday ↗

June 11, 2025

Via Benzinga

Breaking Down Illumina: 11 Analysts Share Their Views ↗

June 11, 2025

Via Benzinga

3 Mid-Cap Stocks Walking a Fine Line

June 11, 2025

Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from...

Via StockStory

ILMN Q1 Earnings Call: Clinical Growth and Cost Actions Offset Research and China Headwinds

June 10, 2025

Genomics company Illumina (NASDAQ:ILMN) reported Q1 CY2025 results beating Wall Street’s revenue expectations, but sales fell by 1.4% year on year to $1.04 billion. Its non-GAAP profit of $0.97 per...

Via StockStory

Topics Economy World Trade

Cathie Wood Sells Tesla Stock As Chinese Rivals Gain Ground — Ark Dumps Palantir Amid Privacy Concerns ↗

June 02, 2025

On Monday, Cathie Wood-led Ark Invest sold shares of Tesla and Palantir, amidst competition and data misuse concerns. Ark also made significant trades in other companies, such as eToro and Illumina.

Via Benzinga

Cathie Wood Reiterates 'Profound' AI Application In Healthcare As Researchers Discover 'Cancer Survival Outcomes' By Facial Photograph Analysis: Here Are The Stocks That Could Benefit ↗

May 26, 2025

Cathie Wood underscored the application of AI in the healthcare sector by sharing new research by Mass General Brigham.

Via Benzinga

Topics Artificial Intelligence

Life Sciences Tools & Services Stocks Q1 Recap: Benchmarking Illumina (NASDAQ:ILMN)

May 25, 2025

Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look at Illumina (NASDAQ:ILMN) and its peers.

Via StockStory

Topics Artificial Intelligence

Danaher, Illumina, Globalstar, and Insperity Shares Plummet, What You Need To Know

May 21, 2025

A number of stocks fell in the afternoon session after the major indices fell further in the afternoon (Nasdaq -1.3%, S&P 500 - 1.4%) as Treasury yields rose, reflecting market anxiety over a draft...

Via StockStory

Topics Bonds Stocks

What 15 Analyst Ratings Have To Say About Illumina ↗

May 20, 2025

Via Benzinga

Genetic Data From 23andMe Ends Up With This Company In $256 Million Deal ↗

May 19, 2025

Regeneron (REGN) to acquire 23andMe for $256 million, plans to maintain consumer services and uphold privacy policies. Deal expected to close Q3 2025.

Via Benzinga

Icahn Ramps Up Bets On Genes And Jets: Illumina Stake Jumps 450%, JetBlue Holding Grow 90% ↗

May 16, 2025

Carl Icahn boosts holdings in Illumina and JetBlue, showing confidence in biotech and airlines. He also trims exposure to Southwest Gas Holdings.

Via Benzinga

3 Volatile Stocks with Mounting Challenges

May 13, 2025

A highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south. While some investors embrace risk, mistakes can be costly for those who aren’t prepared.

Via StockStory

< Previous 1 2 3 4 5 6 7 8 9

...

40 41 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.